Home › Research › Digital health tools
Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
Wood LD, Neumiller JJ, Setter SM, Dobbins EK.. The American journal of geriatric pharmacotherapy, 2010-08-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Parkinson's disease (PD) is associated with a host of nonmotor symptoms, including psychosis, cognitive impairment, depression, sleep disturbance, swallowing disorders, gastrointestinal symptoms, and autonomic dysfunction. Results A total of 148 articles, including RCTs, meta-analyses, and evidence-based reviews, were included in this review. However, the largest study to date found nortriptyline therapy to be efficacious compared with placebo, whereas paroxetine controlled release was not. The challenges associated with nonmotor symptoms must not be forgotten in light of the motor symptoms of PD, and treatment of nonmotor symptoms should be encouraged.
What this study adds
Evidence grade: High
This is a pooled review of 148 participants. This review covers treatment options for nonmotor symptoms of Parkinson's disease, including cognitive impairment, depression, and sleep disturbance. It notes that the largest study to date found nortriptyline efficacious compared with placebo, whereas paroxetine controlled release was not.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wood, L. D., Neumiller, J. J., Setter, S. M., & Dobbins, E. K. (2010). Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease. The American journal of geriatric pharmacotherapy. https://doi.org/10.1016/j.amjopharm.2010.08.002
Vancouver
Wood LD, Neumiller JJ, Setter SM, Dobbins EK. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease. The American journal of geriatric pharmacotherapy. 2010. doi:10.1016/j.amjopharm.2010.08.002. PMID: 20869620.
BibTeX
@article{wood2010-20869620,
author = {Wood, L. D. and Neumiller, J. J. and Setter, S. M. and Dobbins, E. K.},
title = {{Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease}},
journal = {The American journal of geriatric pharmacotherapy},
year = {2010},
doi = {10.1016/j.amjopharm.2010.08.002},
pmid = {20869620},
url = {https://doi.org/10.1016/j.amjopharm.2010.08.002}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Background Parkinson's disease (PD) is associated with a host of nonmotor symptoms, including psychosis, cognitive impairment, depression, sleep disturbance, swallowing disorders, gastrointestinal symptoms, and autonomic dysfunction.
- Results A total of 148 articles, including RCTs, meta-analyses, and evidence-based reviews, were included in this review.
- However, the largest study to date found nortriptyline therapy to be efficacious compared with placebo, whereas paroxetine controlled release was not.
- The challenges associated with nonmotor symptoms must not be forgotten in light of the motor symptoms of PD, and treatment of nonmotor symptoms should be encouraged.
Why it matters
This review covers treatment options for nonmotor symptoms of Parkinson's disease, including cognitive impairment, depression, and sleep disturbance. It notes that the largest study to date found nortriptyline efficacious compared with placebo, whereas paroxetine controlled release was not.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Study designmeta-analysis
- Participants148
- Evidence strengthHigh
How this study scored 53/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for effect reported because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 51 of the 96 points we could judge it on, which is 53 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The American journal of geriatric pharmacotherapy) |
| Journal's citation record | 0 / 4 | The American Journal of Geriatric Pharmacotherapy: journal h-index 73 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2010 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 148 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 74 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.1 citations a year over 18 year(s) since 2010 |
| Impact for its field and year | 3 / 6 | Cited 5.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Erin K. Dobbins holds only 5 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Washington State University Spokane: institution h-index 206 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 20869620) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 51 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 96 points we could judge it on is 53 out of 100. |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Related studies in Digital health tools from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.